The Problem With Clinical Language in Skincare

Skincare now speaks in the grammar of medicine: clinically proven, dermatologist tested, barrier repair, twelve-week study. The vocabulary arrived for defensible reasons and has since become a way of not describing what a product actually does, which is a smaller and more interesting thing than the language admits.

Why the language migrated

Cosmetics occupy a narrow legal space. A product may change the appearance of skin; it may not claim to treat a disease, because that would make it a drug and subject it to a different regulatory regime. The industry therefore developed a vocabulary that sounds clinical without making a medical claim, and the boundary is patrolled by words rather than by evidence.

Clinically tested is the most abused of them. It usually means a study was conducted, not that it was controlled, blinded, large or published. A twelve-week trial of thirty volunteers, run by the company that commissioned it, is a test. It is not nothing. It is also not what a reader imagines when they see the word clinical.

What the vocabulary displaced

The loss is sensory. A generation has learned to evaluate a cream by its ingredient list and its percentage of an active, and has lost the vocabulary for the things that actually determine whether it will be used: how it spreads, how quickly it absorbs, whether it leaves a film, whether the smell is pleasant at seven in the morning. Those are not trivial properties. They decide whether a product is finished.

A cream that is technically excellent and unpleasant to apply will sit in a drawer. A cream that feels good will be used twice a day for years, and use is the only mechanism by which any of it works. The industry knows this, which is why texture is engineered so carefully and described so little.

The percentage arms race

Numbers are comparable, which makes them excellent marketing and poor science. Ten per cent niacinamide is not twice as effective as five, and twenty per cent vitamin C is not better than fifteen; beyond a threshold, the returns flatten and the irritation rises. Formulation, pH, packaging and stability matter more than the headline figure, and none of them fit on a carton.

The result is a market that rewards the largest number, which is a market that rewards the least sophisticated formulation. A brand that puts fifteen per cent on the front of a bottle is making a claim about its marketing department, not about its laboratory.

Packaging is where the same logic hides in plain sight. An airless pump, an opaque bottle and a sealed cartridge are not decoration; they protect unstable actives from light and air, and they cost more than a jar. A jar of a well-formulated antioxidant is a formula designed for the shelf rather than for the skin, because the actives will have oxidised before the third week. The most reliable sign of a serious product is often a dull container that is difficult to open.

The barrier years

Barrier function is real, well understood and genuinely useful as a concept. It has also become the catch-all explanation for every skin problem, which is the fate of any good idea that becomes a marketing category. The honest advice has not changed in forty years and is too boring to sell: cleanse gently, use sunscreen, sleep, do not apply six products when two will do.

Skin cycling, the practice of scheduling actives across a week, is the same logic applied to consumption. It is not harmful. It is a way of making a routine feel like a protocol, and protocols are easier to sell than habits.

What a product is actually for

A cosmetic does two things. It produces a modest physical effect, usually hydration, exfoliation or sun protection, and it produces a psychological one, which is the experience of being cared for. The second is real and should not be sneered at. A morning routine is a small structure in a day that otherwise has none, and the pleasure of a good texture is a legitimate pleasure.

The industry’s mistake is not that it sells hope. Hope is a reasonable thing to sell. The mistake is that it describes hope in the language of a laboratory report, which makes the customer suspicious of the pleasure and credulous about the claims.

Skin is not a clinical problem to be solved. It is an organ that responds to weather, sleep, food, stress and time, and the products that help it are the ones people are willing to use. That is a lower-stakes proposition than the packaging suggests, and a more honest one.

The vocabulary will not retreat, because it sells. But a customer who can say whether a cream is pleasant has a better filter than one who can recite its actives, and the mirror is a more reliable instrument than the study.